{"id":"https://openalex.org/W2184087358","doi":null,"title":"endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients","display_name":"endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2184087358","mag":"2184087358"},"language":"en","primary_location":{"id":"mag:2184087358","doi":null,"is_oa":false,"landing_page_url":"http://lipidworld.com/content/pdf/1476-511x-9-43.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034765284","display_name":"Giovanni Annuzzi","orcid":"https://orcid.org/0000-0002-9324-6047","observed_orcids":["https://orcid.org/0000-0002-9324-6047"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovanni Annuzzi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9324-6047","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056784492","display_name":"Fabiana Piscitelli","orcid":"https://orcid.org/0000-0001-9343-4622","observed_orcids":["https://orcid.org/0000-0001-9343-4622"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabiana Piscitelli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9343-4622","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103463380","display_name":"Lucrezia Di Marino","orcid":"https://orcid.org/0009-0009-9515-2923","observed_orcids":["https://orcid.org/0009-0009-9515-2923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucrezia Di Marino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059694862","display_name":"Lidia Patti","orcid":"https://orcid.org/0000-0002-0674-4188","observed_orcids":["https://orcid.org/0000-0002-0674-4188"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Patti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0674-4188","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041990481","display_name":"Rosalba Giacco","orcid":"https://orcid.org/0000-0002-4006-9761","observed_orcids":["https://orcid.org/0000-0002-4006-9761"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosalba Giacco","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4006-9761","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002790738","display_name":"Giuseppina Costabile","orcid":"https://orcid.org/0000-0001-5761-8002","observed_orcids":["https://orcid.org/0000-0001-5761-8002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppina Costabile","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5761-8002","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029066848","display_name":"Lutgarda Bozzetto","orcid":"https://orcid.org/0000-0001-6549-4476","observed_orcids":["https://orcid.org/0000-0001-6549-4476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lutgarda Bozzetto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6549-4476","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041306496","display_name":"Gabriele Riccardi","orcid":"https://orcid.org/0000-0003-4151-8298","observed_orcids":["https://orcid.org/0000-0003-4151-8298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriele Riccardi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4151-8298","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046726227","display_name":"Roberta Verde","orcid":"https://orcid.org/0000-0002-8103-6616","observed_orcids":["https://orcid.org/0000-0002-8103-6616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roberta Verde","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8103-6616","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067672486","display_name":"Stefania Petrosino","orcid":"https://orcid.org/0000-0002-4263-3987","observed_orcids":["https://orcid.org/0000-0002-4263-3987"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefania Petrosino","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4263-3987","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034305652","display_name":"Angela Albarosa Rivellese","orcid":"https://orcid.org/0000-0002-6525-9780","observed_orcids":["https://orcid.org/0000-0002-6525-9780"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela A. Rivellese","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6525-9780","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Vincenzo Nicol\u00f2 Di","orcid":"https://orcid.org/0000-0003-2604-2172","observed_orcids":["https://orcid.org/0000-0003-2604-2172"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincenzo Nicol\u00f2 Di","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2604-2172","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.03669999912381172,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endocannabinoids","display_name":"endocannabinoids","score":1.0},{"id":"https://openalex.org/keywords/anandamide","display_name":"anandamide","score":0.9020000100135803},{"id":"https://openalex.org/keywords/2-arachidonoylglycerol","display_name":"2-arachidonoylglycerol","score":0.9860000014305115},{"id":"https://openalex.org/keywords/oleoylethanolamide","display_name":"oleoylethanolamide","score":0.9210000038146973},{"id":"https://openalex.org/keywords/palmitoylethanolamide","display_name":"palmitoylethanolamide","score":1.0},{"id":"https://openalex.org/keywords/subcutaneous-adipose-tissue","display_name":"subcutaneous adipose tissue","score":0.972000002861023},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9269999861717224},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.8080000281333923},{"id":"https://openalex.org/keywords/lipoprotein-lipase","display_name":"lipoprotein lipase","score":0.8349999785423279},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7049999833106995},{"id":"https://openalex.org/keywords/hyperinsulinemic-euglycemic-clamp","display_name":"hyperinsulinemic-euglycemic clamp","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pparalpha-ligands","display_name":"PPAR\u03b1 ligands","score":0.7179999947547913},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.652999997138977},{"id":"https://openalex.org/keywords/free-fatty-acids","display_name":"free fatty acids","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8983122110366821},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8823603987693787},{"id":"https://openalex.org/C2779783865","wikidata":"https://www.wikidata.org/wiki/Q410228","display_name":"Anandamide","level":5,"score":0.856611967086792},{"id":"https://openalex.org/C46721173","wikidata":"https://www.wikidata.org/wiki/Q368952","display_name":"Endocannabinoid system","level":3,"score":0.8307232856750488},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.6979496479034424},{"id":"https://openalex.org/C2780613262","wikidata":"https://www.wikidata.org/wiki/Q223739","display_name":"Leptin","level":3,"score":0.6803686618804932},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.6751541495323181},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.567478358745575},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4318254292011261},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.41997456550598145},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.40884965658187866},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4083373546600342},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.36696940660476685},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.34318113327026367},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14270716905593872},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.04632958769798279}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2184087358","doi":null,"is_oa":false,"landing_page_url":"http://lipidworld.com/content/pdf/1476-511x-9-43.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W416021386","https://openalex.org/W1488329806","https://openalex.org/W1491109154","https://openalex.org/W1965837129","https://openalex.org/W1973709235","https://openalex.org/W1976214688","https://openalex.org/W1985712631","https://openalex.org/W1991334358","https://openalex.org/W2007190600","https://openalex.org/W2010474996","https://openalex.org/W2018029405","https://openalex.org/W2020216434","https://openalex.org/W2024269680","https://openalex.org/W2026530510","https://openalex.org/W2042999271","https://openalex.org/W2048520615","https://openalex.org/W2054324237","https://openalex.org/W2056611518","https://openalex.org/W2061169432","https://openalex.org/W2063663168","https://openalex.org/W2067881925","https://openalex.org/W2071904759","https://openalex.org/W2080373548","https://openalex.org/W2082104703","https://openalex.org/W2088281975","https://openalex.org/W2094153715","https://openalex.org/W2098174994","https://openalex.org/W2098631687","https://openalex.org/W2104652079","https://openalex.org/W2107895127","https://openalex.org/W2117507851","https://openalex.org/W2119670722","https://openalex.org/W2142451287","https://openalex.org/W2156077387","https://openalex.org/W2158807350","https://openalex.org/W2162112945"],"related_works":["https://openalex.org/W2071805619","https://openalex.org/W2024269680","https://openalex.org/W3036866210","https://openalex.org/W7097018716","https://openalex.org/W2035826469","https://openalex.org/W2117507851","https://openalex.org/W6986766302","https://openalex.org/W1555539048","https://openalex.org/W3203183761","https://openalex.org/W2063663168"],"abstract_inverted_index":{"Background:":[0],"The":[1,92,213],"endocannabinoids,":[2],"anandamide":[3,95,232],"and":[4,19,27,39,63,72,77,90,96,98,106,122,148,160,177,188,195,201,227,236,240],"2-AG,":[5,97],"are":[6,20,31],"produced":[7],"by":[8,69,113,130],"adipocytes,":[9],"where":[10],"they":[11],"stimulate":[12],"lipogenesis":[13],"via":[14],"cannabinoid":[15],"CB":[16],"1":[17],"receptors":[18],"under":[21],"the":[22,34,100,110,152,218,223],"negative":[23],"control":[24],"of":[25,36,58,94,99,229],"leptin":[26,80,186],"insulin.":[28],"Endocannabinoid":[29],"levels":[30,52,81,93,150,162],"elevated":[32,156],"in":[33,53,109,117,151,168,172,209,221,238],"blood":[35],"obese":[37,86],"individuals":[38],"nonobese":[40],"type":[41,64,241],"2":[42,65,242],"diabetes":[43,66],"patients.":[44],"To":[45],"date,":[46],"no":[47],"study":[48],"has":[49],"evaluated":[50],"endocannabinoid":[51],"subcutaneous":[54],"adipose":[55,230],"tissue":[56,231],"(SAT)":[57],"subjects":[59,87,135],"with":[60,184,197],"both":[61],"obesity":[62,239],"(OBT2D),":[67],"characterised":[68],"similar":[70],"adiposity":[71],"whole":[73],"body":[74],"insulin":[75],"resistance":[76],"lower":[78],"plasma":[79,202],"as":[82],"compared":[83,143],"to":[84,144],"non-diabetic":[85,124],"(OB).":[88],"Design":[89],"Methods:":[91],"anandamide-related":[101],"PPAR\u03b1":[102],"ligands,":[103],"oleoylethanolamide":[104],"(OEA)":[105],"palmitoylethanolamide":[107],"(PEA),":[108],"SAT":[111,153,185,198],"obtained":[112],"abdominal":[114],"needle":[115],"biopsy":[116],"10":[118],"OBT2D,":[119],"11":[120],"OB,":[121],"8":[123],"normal-weight":[125],"(NW)":[126],"subjects,":[127],"were":[128,154,205],"measured":[129],"liquid":[131],"chromatography-mass":[132],"spectrometry.":[133],"All":[134],"underwent":[136],"a":[137],"hyperinsulinaemic":[138,193],"euglycaemic":[139],"clamp.":[140],"Results:":[141],"As":[142],"NW,":[145],"anandamide,":[146],"OEA":[147,176],"PEA":[149,178],"2-4.4-fold":[155],"(p":[157,165,181],"<":[158,166,182],"0.05),":[159],"2-AG":[161,237],"2.3-fold":[163],"reduced":[164],".05),":[167],"OBT2D":[169,210],"but":[170],"not":[171],"OB":[173],"subjects.":[174,211],"Anandamide,":[175],"correlated":[179],"positively":[180],".05)":[183],"mRNA":[187],"free":[189],"fatty":[190],"acid":[191],"during":[192],"clamp,":[194],"negatively":[196],"LPL":[199],"activity":[200],"HDL-cholesterol,":[203],"which":[204],"all":[206],"specifically":[207],"altered":[208],"Conclusions:":[212],"observed":[214],"alterations":[215],"emphasize,":[216],"for":[217],"first":[219],"time":[220],"humans,":[222],"potential":[224],"different":[225],"role":[226],"regulation":[228],"(and":[233],"its":[234],"congeners)":[235],"diabetes.":[243]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}